A Hot Water Extract of Curcuma longa L. Improves Fasting Serum Glucose Levels in Participants with Low-Grade Inflammation: Reanalysis of Data from Two Randomized, Double-Blind, Placebo-Controlled Trials

Nutrients. 2022 Sep 13;14(18):3763. doi: 10.3390/nu14183763.

Abstract

The dietary spice Curcuma longa L. (C. longa), also known as turmeric, has various biological effects. A hot water extract of C. longa was shown to have anti-inflammatory activities in preclinical and clinical studies. Chronic low-grade inflammation is associated with the disruption of glucose homeostasis, but the effect of C. longa extract on glucose metabolism in humans is poorly understood. Therefore, we investigated the effect of C. longa extracts on serum glucose levels in the presence of low-grade inflammation. We reanalyzed our published data from two randomized, double-blind, placebo-controlled trials in overweight participants aged 50 to 69 years and performed a stratified analysis using the inflammatory marker high-sensitivity C-reactive protein (hsCRP). In both studies, participants took a test food with a hot water extract of C. longa (C. longa extract group, n = 45 per study) or without C. longa extract (placebo group, n = 45 per study) daily for 12 weeks, and we measured the levels of serum hsCRP and fasting serum glucose. The mean baseline hsCRP value was used to stratify participants into two subgroups: a low-hsCRP subgroup (baseline mean hsCRP < 0.098 mg/dL) and a high-hsCRP subgroup (baseline mean hsCRP ≥ 0.098 mg/dL). In the low-hsCRP subgroup, we found no significant difference in fasting serum glucose levels between the two groups in either study, but in the high-hsCRP subgroup, the C. longa extract group had significantly lower levels of serum hsCRP (p < 0.05) and fasting serum glucose (p < 0.05) than the placebo group in both studies. In conclusion, a hot water extract of C. longa may help to improve systemic glucose metabolism in people with chronic low-grade inflammation.

Keywords: C-reactive protein (CRP); bisacurone; chronic inflammation; glucose; turmeric (Curcuma longa); turmeronol.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Anti-Inflammatory Agents / therapeutic use
  • C-Reactive Protein*
  • Curcuma*
  • Double-Blind Method
  • Fasting
  • Glucose / therapeutic use
  • Humans
  • Inflammation / drug therapy
  • Plant Extracts / therapeutic use
  • Water

Substances

  • Anti-Inflammatory Agents
  • Plant Extracts
  • Water
  • C-Reactive Protein
  • Glucose

Grants and funding

These studies received no external funding and were conducted by CRO (CPCC Co., Ltd., Tokyo, Japan) with financial support from House Wellness Foods Corp (Itami, Japan). The article processing charges was founded by House Wellness Foods Corp.